The New Hepatitis C Effective Clinical Management in the Age of All-Oral Therapy

Author: Hagendorf, Col

Be the first to review this product

Availability: In stock

Regular Price AED 255.56 Special Price AED 242.78

Qty:

Cash on Delivery in UAE
Dispatches in 3 to 5 Working Days.

BISAC Categories:
Gastroenterology |

Description

Fueled in part by the opioid epidemic, the number of reported hepatitis C virus infections tripled in the United States between 2010 and 2015. As new infections continue to mount, new therapies have produced seismic changes in how HCV is treated clinically, leaving a gap between the most current clinical guidance and the ongoing demands of patient care.

The New Hepatitis C is a current and essential review of HCV's epidemiology, diagnosis, and clinical approaches -- a clinician's guidebook for navigating everything from screening to treatment. Acute and chronic HCV are addressed, as are important new treatment options for HCV, management of side effects, and a convenient summary of clinical trials on the treatment of chronic hepatitis C.

Updated to detail the standards of care that will define the next decade of HCV management, this evidence-based volume is an essential clinical reference for to any practitioner in gastroenterology, hepatology, infectious disease, transplant, or internal medicine.

More Details

Publisher Name	Oxford University Press USA
Author Name	Hagendorf, Col
Format	Audio
Bisac Subject Major	MED
Language	NG
Isbn 10	0190238283
Isbn 13	9780190238285
Target Age Group	min:NA, max:NA
Series	000369087
Dimensions	00.79" H x 00.05" L x 00.00" W
Page Count	200

Author Details

Nancy Reau, MD, is Professor of Medicine, Chief of Hepatology, and Associate Director of Solid Organ Transplantation at Rush University Medical Center in Chicago.

Donald M. Jensen, MD, is Professor of Medicine at Rush University Medical Center in Chicago.

Review(s)

Write Your Own Review